Factors to Consider for the Correct Use of γH2AX in the Evaluation of DNA Double-Strand Breaks Damage Caused by Ionizing Radiation.

DNA damage DNA repair basal level double-strand breaks (DSBs) ionizing radiation γH2AX scoring

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
15 Dec 2022
Historique:
received: 22 11 2022
revised: 07 12 2022
accepted: 13 12 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 24 12 2022
Statut: epublish

Résumé

People exposed to ionizing radiation (IR) both for diagnostic and therapeutic purposes is constantly increasing. Since the use of IR involves a risk of harmful effects, such as the DNA DSB induction, an accurate determination of this induced DNA damage and a correct evaluation of the risk-benefit ratio in the clinical field are of key relevance. γH2AX (the phosphorylated form of the histone variant H2AX) is a very early marker of DSBs that can be induced both in physiological conditions, such as in the absence of specific external agents, and by external factors such as smoking, heat, background environmental radiation, and drugs. All these internal and external conditions result in a basal level of γH2AX which must be considered for the correct assessment of the DSBs after IR exposure. In this review we analyze the most common conditions that induce H2AX phosphorylation, including specific exogenous stimuli, cellular states, basic environmental factors, and lifestyles. Moreover, we discuss the most widely used methods for γH2AX determination and describe the principal applications of γH2AX scoring, paying particular attention to clinical studies. This knowledge will help us optimize the use of available methods in order to discern the specific γH2AX following IR-induced DSBs from the basal level of γH2AX in the cells.

Identifiants

pubmed: 36551689
pii: cancers14246204
doi: 10.3390/cancers14246204
pmc: PMC9776434
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Ministero della Salute
ID : Ricerca corrente

Références

Cell Cycle. 2009 Jun 15;8(12):1853-9
pubmed: 19448405
DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1109-15
pubmed: 15279799
Mol Cell. 2008 Jul 11;31(1):33-46
pubmed: 18614045
Environ Mol Mutagen. 2009 May;50(4):337-48
pubmed: 19306413
Crit Rev Food Sci Nutr. 2004;44(4):275-95
pubmed: 15462130
Mutat Res Genet Toxicol Environ Mutagen. 2022 Jan;873:503436
pubmed: 35094811
FEBS Lett. 2006 Nov 13;580(26):6161-8
pubmed: 17064697
DNA Repair (Amst). 2008 Oct 1;7(10):1765-71
pubmed: 18675941
Health Phys. 2010 Feb;98(2):209-17
pubmed: 20065685
Mol Cell. 2012 Dec 14;48(5):723-33
pubmed: 23122415
Mol Cell Biol. 2009 Jan;29(2):526-37
pubmed: 18981219
Nat Rev Cancer. 2008 Dec;8(12):957-67
pubmed: 19005492
Ann Biol Clin (Paris). 1994;52(3):199-204
pubmed: 7998676
Int J Radiat Biol. 2012 May;88(5):439-47
pubmed: 22280362
Curr Biol. 2000 Jul 27-Aug 10;10(15):886-95
pubmed: 10959836
Cell Prolif. 2007 Feb;40(1):1-13
pubmed: 17227291
Mol Cell. 2004 Dec 22;16(6):1003-15
pubmed: 15610742
Int J Radiat Biol. 2022;98(3):421-427
pubmed: 34515621
Health Phys. 2005 Nov;89(5):494-504
pubmed: 16217193
PLoS One. 2015 Mar 20;10(3):e0121083
pubmed: 25794041
Semin Immunol. 1997 Jun;9(3):189-97
pubmed: 9200330
Anal Quant Cytol Histol. 2012 Apr;34(2):66-71
pubmed: 22611761
Nat Genet. 2001 Mar;27(3):247-54
pubmed: 11242102
Radiat Oncol. 2009 Aug 24;4:31
pubmed: 19703306
Cell Cycle. 2006 Sep;5(17):1940-5
pubmed: 16940754
Int J Radiat Biol. 2006 Sep;82(9):605-39
pubmed: 17050475
Mutat Res. 2009 Aug;678(1):43-52
pubmed: 19591958
Biochem Biophys Res Commun. 2005 Oct 28;336(3):807-12
pubmed: 16153602
Cell Cycle. 2006 Apr;5(8):878-82
pubmed: 16628006
Toxicology. 2015 May 4;331:57-65
pubmed: 25772433
Radiat Res. 2017 May;187(5):630-636
pubmed: 28240558
Proc Natl Acad Sci U S A. 1981 Apr;78(4):2383-7
pubmed: 6941298
Annu Rev Genet. 2006;40:363-83
pubmed: 16895466
J Radiol Prot. 2019 Jun 19;39(4):S28-S39
pubmed: 31216522
Curr Opin Cell Biol. 2001 Apr;13(2):225-31
pubmed: 11248557
N Engl J Med. 2007 Nov 29;357(22):2277-84
pubmed: 18046031
Circulation. 2009 Nov 10;120(19):1903-9
pubmed: 19858412
FEBS Lett. 2010 Sep 10;584(17):3682-95
pubmed: 20655309
Cancer Res. 2007 Apr 1;67(7):3010-7
pubmed: 17409407
Cell Cycle. 2009 Dec 15;8(24):4112-8
pubmed: 19946210
Arch Oral Biol. 2022 Jan;133:105296
pubmed: 34735927
J Radiat Res. 2010;51(5):493-501
pubmed: 20814172
J Community Genet. 2013 Jan;4(1):21-31
pubmed: 22875746
Hawaii J Med Public Health. 2015 Mar;74(3):112-9
pubmed: 25821654
Dose Response. 2018 Sep 19;16(3):1559325818796331
pubmed: 30263019
FEBS Lett. 2005 Nov 21;579(28):6338-42
pubmed: 16256111
Mol Cell. 2005 Dec 9;20(5):801-9
pubmed: 16310392
Cancer Res. 2010 Dec 15;70(24):10019-23
pubmed: 21159626
Biochem Biophys Res Commun. 2005 Mar 25;328(4):1101-6
pubmed: 15707990
Indian J Med Res. 2014 Nov;140 Suppl:S120-9
pubmed: 25673532
Int J Radiat Biol. 2011 Aug;87(8):776-90
pubmed: 21557703
Proc Natl Acad Sci U S A. 1976 Aug;73(8):2881-4
pubmed: 822422
Probl Radiac Med Radiobiol. 2014 Sep;19:186-91
pubmed: 25536556
Cell Cycle. 2006 May;5(10):1116-22
pubmed: 16721046
Proc ASME Des Eng Tech Conf. 2009 Jan 1;3:61-67
pubmed: 21258614
Cell. 1997 Feb 7;88(3):375-84
pubmed: 9039264
J Biol Chem. 2003 Apr 4;278(14):12207-13
pubmed: 12519769
CA Cancer J Clin. 2012 Mar-Apr;62(2):75-100
pubmed: 22307864
Phys Med. 2020 Aug;76:173-176
pubmed: 32693353
Cell Cycle. 2010 Jun 1;9(11):2170-6
pubmed: 20404482
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12871-6
pubmed: 14566050
Nature. 2014 Oct 2;514(7520):39-40
pubmed: 25231858
Biochem Soc Trans. 2007 Nov;35(Pt 5):1147-50
pubmed: 17956298
Zhonghua Yi Xue Za Zhi. 1999 Jul;79(7):487-92
pubmed: 11715418
Hum Exp Toxicol. 2013 Dec;32(12):1311-22
pubmed: 23698832
Aging Cell. 2008 Jan;7(1):89-100
pubmed: 18005250
Environ Health Perspect. 2005 Sep;113(9):1172-7
pubmed: 16140623
Mutagenesis. 2009 May;24(3):279-84
pubmed: 19273466
J Cell Biochem. 2005 Feb 1;94(2):298-306
pubmed: 15578575
Curr Biol. 2001 Mar 20;11(6):R229-32
pubmed: 11301269
Radiat Res. 2006 Jan;165(1):113-24
pubmed: 16392969
Epigenetics. 2010 Feb 16;5(2):129-36
pubmed: 20150765
Nat Cell Biol. 2022 Feb;24(2):135-147
pubmed: 35165420
Mol Cell Biol. 2009 Jan;29(1):68-82
pubmed: 18955500
Proc Natl Acad Sci U S A. 2012 Aug 7;109(32):12866-72
pubmed: 22753480
EMBO J. 1994 Apr 15;13(8):1899-910
pubmed: 8168488
Biol Chem. 2013 Apr;394(4):519-28
pubmed: 23241668
Cell Mol Life Sci. 2014 Jun;71(12):2289-97
pubmed: 24448903
Invest Radiol. 2009 Aug;44(8):440-6
pubmed: 19448553
Cancers (Basel). 2021 Nov 05;13(21):
pubmed: 34771723
Mol Cell. 2006 Jul 7;23(1):121-32
pubmed: 16818236
Cancer Lett. 2012 Dec 31;327(1-2):123-33
pubmed: 22198208
Physiol Rev. 2002 Jan;82(1):47-95
pubmed: 11773609
Methods Mol Biol. 2021;2153:1-8
pubmed: 32840768
DNA Repair (Amst). 2019 Jan;73:110-119
pubmed: 30497961
J Biol Chem. 2011 Sep 2;286(35):30806-30815
pubmed: 21690091
Mutat Res. 2013 Oct;750(1-2):5-14
pubmed: 23916969
Oncotarget. 2016 Aug 2;7(31):49574-49587
pubmed: 27391338
DNA Repair (Amst). 2021 Jun;102:103100
pubmed: 33812230
PLoS One. 2014 Aug 05;9(8):e103993
pubmed: 25093845
Exp Cell Res. 1994 Apr;211(2):314-21
pubmed: 8143779
Cell Prolif. 2005 Aug;38(4):223-43
pubmed: 16098182
DNA Repair (Amst). 2020 Sep;93:102915
pubmed: 33087281
Eur Radiol. 2022 Aug;32(8):5491-5498
pubmed: 35230516
Mutat Res. 2004 Jul 13;551(1-2):79-89
pubmed: 15225583
J Vis Exp. 2017 Nov 3;(129):
pubmed: 29155797
Int J Mol Sci. 2013 Jul 30;14(8):15810-26
pubmed: 23903043
Cytometry A. 2006 Apr;69(4):222-9
pubmed: 16528736
J Biol Chem. 1997 Aug 8;272(32):19633-6
pubmed: 9289489
FEBS J. 2005 Jul;272(13):3231-40
pubmed: 15978030
Subcell Biochem. 2010;50:55-78
pubmed: 20012577
Cancer Res. 2010 Aug 15;70(16):6427-36
pubmed: 20647318
Mol Cell. 2004 Dec 22;16(6):991-1002
pubmed: 15610741
Cancer Res. 2011 Feb 1;71(3):906-13
pubmed: 21148072
Biol Reprod. 2006 Nov;75(5):673-80
pubmed: 16855210
Br J Radiol. 1997 Feb;70:130-9
pubmed: 9135438
Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):331-5
pubmed: 14751500
J Biol Chem. 2000 Mar 31;275(13):9390-5
pubmed: 10734083
Sci Rep. 2019 Sep 30;9(1):14019
pubmed: 31570741
Physiol Rev. 2007 Jan;87(1):315-424
pubmed: 17237348
Int J Oncol. 2006 Aug;29(2):495-501
pubmed: 16820894
Cell Signal. 2007 Sep;19(9):1807-19
pubmed: 17570640
Radiat Prot Dosimetry. 2017 Jun 1;175(1):1-9
pubmed: 27614298
Mutat Res Rev Mutat Res. 2021 Jan-Jun;787:108350
pubmed: 34083048
J Nucl Med. 2010 Aug;51(8):1318-25
pubmed: 20660387
Cancer Res. 2003 Aug 1;63(15):4347-50
pubmed: 12907603
Nature. 1965 Sep 25;207(5004):1402-3
pubmed: 5886053
Nucleic Acids Res. 2007;35(5):e36
pubmed: 17284459
PLoS One. 2015 Jun 11;10(6):e0129416
pubmed: 26067661
Appl Immunohistochem Mol Morphol. 2008 Jul;16(4):349-56
pubmed: 18528282
Mutat Res. 2010 Feb;696(1):16-20
pubmed: 20018253
Cell Cycle. 2004 Aug;3(8):1062-8
pubmed: 15254392
J Cell Biol. 1999 Sep 6;146(5):905-16
pubmed: 10477747
Mol Biol Cell. 2005 Oct;16(10):5013-25
pubmed: 16030261
Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):521-531
pubmed: 30312716
J Biol Chem. 1998 Mar 6;273(10):5858-68
pubmed: 9488723
Proc Natl Acad Sci U S A. 2005 Jun 21;102(25):8984-9
pubmed: 15956203
J Clin Pathol. 2001 Mar;54(3):176-86
pubmed: 11253127
Radiat Res. 2003 Jun;159(6):759-67
pubmed: 12751958
PLoS One. 2012;7(9):e45728
pubmed: 23029205
J Cell Physiol. 2005 Feb;202(2):492-502
pubmed: 15389585

Auteurs

Davide Valente (D)

Unit of Cellular Networks and Molecular Therapeutic Targets, Department of Research and Advanced Technologies, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Maria Pia Gentileschi (MP)

Unit of Cellular Networks and Molecular Therapeutic Targets, Department of Research and Advanced Technologies, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Antonino Guerrisi (A)

Unit of Radiology and Diagnostic Imaging, Department of Clinical and Dermatological Research, IRCCS San Gallicano Dermatological Institute, 00144 Rome, Italy.

Vicente Bruzzaniti (V)

Unit of Medical Physics and Expert Systems, Department of Research and Advanced Technologies, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Aldo Morrone (A)

Scientific Direction, IRCCS San Gallicano Dermatological Institute, 00144 Rome, Italy.

Silvia Soddu (S)

Unit of Cellular Networks and Molecular Therapeutic Targets, Department of Research and Advanced Technologies, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Alessandra Verdina (A)

Unit of Cellular Networks and Molecular Therapeutic Targets, Department of Research and Advanced Technologies, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Classifications MeSH